The new Signa Vibrant, a new dedicated 1.5T breast MR scanner using high-definition (HD) technology and applications specifically designed for breast MR, is the latest offering from GE Healthcare. Its features include VIBRANT acquisition, BREASE spectroscopy, integrated CADstream (manufactured by Confirma) and a specially designed breast MR patient table. To help improve public awareness and knowledge of breast cancer, GE will apply a portion of the proceeds from Signa Vibrant sales toward breast cancer education and awareness programs.

The new 256-slice Brilliance iCT scanner by Philips provides 8 centimeters of coverage to capture the entire heart in two scans with a rotation speed of 0.27 seconds with 120 kw of power.
The Brilliance iCT scanner is four times more powerful than a 64-slice CT and is designed to produce high-quality images with exceptional acquisition speed, complete coverage of the heart and brain, while reportedly reducing radiation doses by up to 80 percent.

Artis zeego is the new multi-axis C-arm by Siemens Medical Solutions, which employs robotic technology to extend imaging capabilities through various C-arm positions.

The AquilionONE is a new advanced diagnostic imaging system by Toshiba America
Medical Systems that leverages dynamic volume computed tomography (CT) imaging to capture an entire organ in a single rotation or over multiple rotations to show real-time dynamic movement.
Additionally, multiphase studies, such as perfusion of the brain, heart and other organs, are possible with the AquilionONE. The system covers up to 16 centimeters of anatomy using 320 ultra high-resolution 0.5-millimeter
detector elements, producing images designed to promote greater clinical accuracy.

February 4, 2008 - Tryton Medical Inc. said it has received CE Mark approval for its Side-Branch Stent, a cobalt chromium balloon-expandable coronary stent specifically developed for the complete treatment of the entire spectrum of coronary artery bifurcation disease.

Approximately 540,000 annual procedures are performed to address bifurcation lesions, accounting for 20% of all coronary lesions treated. With the exception of Tryton's stent, no dedicated solution exists today that fully addresses these lesions, according to the company.

February 5, 2008 - Mitralign Inc. said it successfully performed its first implantation of the Mitralign Percutaneous Annuloplasty System for mitral valve repair at French Hospital in Asuncion, Paraguay.

February 5, 2008 - CytoCore Inc. said today that the FDA has approved the company's 510(k) submission to sell CytoCore's SoftPAP cervical cell collector.

The SoftPAP collects more comprehensive and complete cervical cell specimens for Pap testing, according to CytoCore.

February 5, 2008 - Endologix Inc., developer and manufacturer of the Powerlink System endoluminal stent graft (ELG) for the minimally invasive treatment of abdominal aortic aneurysms (AAA), today noted a study published in the Jan. 31 issue of the New England Journal of Medicine comparing results of AAA repair following open surgery and endovascular repair.

February 4, 2008 - CV Therapeutics Inc. and Medlogics Device Corporation announced today that the companies have entered into an agreement under which Medlogics has licensed CV Therapeutics’ proprietary biopolymer stent coating technology to develop a drug eluting stent (DES).

February 5, 2008 - New polymer material designed to stop bone bleeding in surgery reduces the risk of surgical infection, according to a new animal study to be published in the Feb. 2008 issue of Clinical Orthopaedics and Related Research (CORR).

The study has implications for lowering the risk of hospital-acquired infections, including MRSA.

Subscribe Now